Edition:
United Kingdom

Marksans Pharma Ltd (MARK.NS)

MARK.NS on National Stock Exchange of India

38.80INR
23 Feb 2018
Change (% chg)

Rs0.60 (+1.57%)
Prev Close
Rs38.20
Open
Rs38.60
Day's High
Rs39.25
Day's Low
Rs38.50
Volume
2,279,573
Avg. Vol
4,794,202
52-wk High
Rs58.25
52-wk Low
Rs34.20

Chart for

About

Marksans Pharma Limited is a pharmaceutical holding company. The Company is engaged in the research, manufacturing and marketing of generic pharmaceutical formulations. The Company's product portfolio addresses various therapeutic segments, including Pain management, Cough and cold, Anti-diabetic, Cardiovascular system, Central... (more)

Overall

Beta: 1.92
Market Cap(Mil.): Rs19,606.13
Shares Outstanding(Mil.): 409.31
Dividend: 0.05
Yield (%): 0.10

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.60
EPS (TTM): -- -- --
ROI: -- 14.91 10.66
ROE: -- 16.41 14.30

BRIEF-India's Marksans Pharma Dec-Qtr Consol Profit Rises

* DEC QUARTER CONSOL PROFIT 174.6 MILLION RUPEES VERSUS PROFIT 115.2 MILLION RUPEES YEAR AGO

12 Feb 2018

BRIEF-India's Marksans Pharma Sept-qtr consol profit rises

* Sept quarter consol profit 104.1 million rupees versus profit of 7.5 million rupees year ago

13 Nov 2017

BRIEF-Marksans Pharma gets EIR from U.S. FDA for inspection of Goa facility‍​‍​

* Says got EIR from U.S. Fda for inspection of co's Goa facility

09 Oct 2017

Earnings vs. Estimates